MAIA Biotechnology Return on Equity (ROE) Growth & History (MAIA)
MAIA Biotechnology's return on equity was −745.24% for fiscal 2025.
View full MAIA Biotechnology company overviewMAIA Biotechnology annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −745.24% | +385.79 pp |
| 2024 | 2024-12-31 | −1,131.02% | −690.91 pp |
| 2023 | 2023-12-31 | −440.12% | −261.82 pp |
| 2022 | 2022-12-31 | −178.29% | — |
MAIA Biotechnology quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −32.80% | +88.46 pp |
| Q1 2026 | 2026-03-31 | −42.27% | +63.06 pp |
| Q4 2025 | 2025-12-31 | −300.20% | −164.21 pp |
| Q3 2025 | 2025-09-30 | −454.44% | −339.97 pp |
| Q2 2025 | 2025-06-30 | −121.26% | — |
| Q1 2025 | 2025-03-31 | −105.33% | — |
| Q4 2024 | 2024-12-31 | −135.99% | +251.99 pp |
| Q3 2024 | 2024-09-30 | −114.46% | −13.12 pp |
| Q4 2023 | 2023-12-31 | −387.98% | −347.77 pp |
| Q3 2023 | 2023-09-30 | −101.35% | −49.10 pp |
| Q2 2023 | 2023-06-30 | −75.66% | −33.93 pp |
| Q1 2023 | 2023-03-31 | −60.58% | — |
| Q4 2022 | 2022-12-31 | −40.21% | — |
| Q3 2022 | 2022-09-30 | −52.24% | — |
| Q2 2022 | 2022-06-30 | −41.73% | — |
MAIA Biotechnology return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, MAIA Biotechnology's return on equity decreased from −178.29% to −745.24%, a change of −566.94 percentage points. The latest reported quarter, Q2 2026, shows −32.80%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MAIA Biotechnology source filings ↗